Oncology Institute issues FY2023 results slide presentation; no specific figures in filing excerpt

Oncology Institute, Inc.

2024-Q1 EPS reported -$0.22 revenue$94,666,000

Presentation covers financial results for Q4 and full year ended Dec 31, 2023.
Company also provided business updates and guidance for the year ending Dec 31, 2023.
No quantitative data (revenue, EPS, etc.) appears in the provided excerpt of Exhibit 99.1.
Investors should review the full slide deck for actual performance metrics.
Filing date April 3, 2024; tickers TOI and TOIIW.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

Oncology Institute, Inc. reported financial results for the three months and year ended December 31, 2023.

Period: the three months and year ended December 31, 2023
Result: reported results

Exact text from the filing

On April 3, 2024, The Oncology Institute, Inc. (the "Company") issued a slide presentation which includes the Company's financial results for the three months and year ended December 31, 2023 and certain other financial information.

View on SEC.gov

321 earnings releases filed in the last 30 days. Browse all earnings releases →

Oncology Institute, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-014573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.